Diabetic cardiomyopathy

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue 3, 2004, Pages 261-265

  Feuvray, D ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Fatty acid oxidation; Glucose utilization; Insulin signalling; Myocardial metabolism; Type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE; FATTY ACID; GLUCOSE; INSULIN;

CARDIOMYOPATHY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIET; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUCOSE UTILIZATION; HEART MUSCLE METABOLISM; HORMONAL REGULATION; HUMAN; INSULIN DEFICIENCY; INSULIN RESISTANCE; LIPID STORAGE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN CONSUMPTION; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FATTY ACIDS; FEMALE; GLUCOSE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; MICE; MITOCHONDRIA, HEART; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; MYOCARDIUM; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 1842429948     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999; 48: 937-42.
2. Nathan DM, Meigs J, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is... or is it? Lancet 1997; 350: 4-9.
3. Shehadeh A, Regan TJ. Cardiac consequences of diabetes mellitus. Clin Cardiol 1995; 18: 301-5.
4. Devereux RB, Roman MJ, Paranicas M et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000; 101: 2271-6.
5. Frustaci A, Kajstura J, Chimenti C et al. Myocardial cell death in human diabetes. Circ Res 2000; 87: 1123-32.
6. Galderisi M, Anderson KM, Wilson PWF et al. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy: the Framingham Heart Study. Am J Cardiol 1991; 68: 85-9.
7. Feuvray D, Idell-Wenger JA, Neely JR. Effects of ischemia in rat myocardial function and metabolism in diabetes. Circ Res 1979; 44: 322-9.
8. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997; 34: 25-33.
9. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15: 289-329.
10. Stephens J, Pilch P. TRe metabolic regulation and vesicular transport of GLUT4, the major insulin-responsive glucose transporter. Endocr Rev 1995; 16: 529-46.
11. Fischer Y, Thomas J, Sevilla L et al. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J Biol Chem 1997; 272: 7085-92.
12. Egert S, Nguyen N, Schwaiger M. Myocardial glucose transporter GLUT1: translocation induced by insulin and ischemia. J Mol Cell Cardiol 1999; 31: 1337-44.
13. Saltiel AR, Pessin JE. Insulin signalling pathways in time and space. Trends Cell Biol 2002; 12: 65-71.
14. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806.
15. Hue L, Beauloye C, Marsin A-S, Bertrand L, Horman S, Rider MH. Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signalling pathways. J Mol Cell Cardiol 2002; 34: 1091-7.
16. Alessi DR. Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture. Biochem Soc Trans 2001; 29: 1-14.
17. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998; 67: 821-55.
18. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl CoA levels due to an increase in 5′AMP-activated protein kinase inhibition of acetyl CoA carboxylase. J Biol Chem 1995; 270: 17513-20.
19. Makinde AO, Gamble J, Lopaschuk GD. Upregulation of 5′ -AMP-activated protein kinase is responsible for the increase in myocardial fatty acidoxiclation rates following birth in the newborn rabbit. Circ Res 1997; 80: 482-9.
20. Beauloye C, Marsin AS, Bertrand L et al. Insulin antagonizes AMP-activated protein activation by ischemia or anoxia in rat hearts without affecting total adenine nucleotides. FEBS Lett 2001; 505: 348-52.
21. Rodrigues B, Cam MC, McNeill JH. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol 1995; 27: 169-79.
22. Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 2000; 10: 238-45.
23. Finck BN, Lehman JJ, Leone TC et al. The cardiac phenotype induced by PPARa overexpression mimics that caused by diabetes mellitus. J Clin Invest 2002; 109: 121-30.
24. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997; 80: 3A-10A.
25. Lewandowski ED, White LT. Pyruvate dehydrogenase influences postischemic heart function. Circulation 1995; 91: 2071-9.
26. Frayne KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4: 197-204.
27. McGarry JD. What if Minkowski had been agueusic? An alternative angle on diabetes. Science 1992; 258: 766-70.
28. Dresner A, Lourent D, Morcucci M et al. Effects of free fatty acids on glucose transport and IRS-1 associated phosphotidylinositol 3-kinase activity. J Clin Invest 1999; 103: 253-9.
29. Griffin ME, Marcucci MJ, Cline GW et al. Free fatty acid-induced insulin resistance is associated with activity of protein kinase C theta and alterations in the insulin signalling cascade. Diabetes 1999; 48: 1270-4.
30. + exchange in diabetic rat isolated ventricular myocytes. Circ Res 1997; 80: 253-60.
31. + exchange. Structure, regulation, and its role in heart disease. Circ Res 1999; 85: 777-86.
32. + exchanger inhibition: a new antihypertrophic tool. Circ Res 2002; 90: 751-3.
33. + exchanger activity: signalling and significance. Cardiovasc Res 2003; 57: 942-52.
34. Feuvray D. The regulation of intracellular pH in the diabetic myocardium. Cardiovasc Res 1997; 34: 48-54.
35. + exchanger in the diabetic heart. In: Karmazyn M, Avkiran M, Fliegel L (eds). The sodium-hydrogen exchanger. From molecule to its role in heart disease. Boston, Dordrect, London, Kluwer Academic Publischers, 2003: 149-58.
36. Hileeto D, Cukiernik M, Mukherjee S et al. Contributions of endothelin-1 and sodium hydrogen exchanger in the diabetic myocardium. Diabetes Metab Res Rev 2002; 18: 386-394.
37. + exchange activity in type 2 diabetes. Eur J Heart Failure 2003; 2: 42 (abstract).